- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
- Locations
-
- N.N. Alexandrov National Caner Centre Minsk, Lesnoy, Belarus
Clinical trial condition
Metastatic Cervical Cancer
Explore clinical trials studying Metastatic Cervical Cancer. Study availability and eligibility vary by location and protocol.
13 public trials
5 recruiting studies
Metastatic Cervical Cancer trial results
Recruiting
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
NCT06157151
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- National Institute of Health Bethesda, Maryland, United States
- University of Washington Seattle, Washington, United States
NCT07418749
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT04865887
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- John Theurer Cancer Center at Hackensack UMC Hackensack, New Jersey, United States
NCT06771193
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Oncologia Medica Policlinico Sant'Orsola Malpighi Bologna, Italy
- Ginecologia ed Ostetricia A.O. Cannizzaro Catania, Italy
- Oncologia Medica 1 IRCCS Ospedale Policlinico San Martino Genova, Italy
- Unità di Ginecologia Oncologica Medica IRCCS Ospedale San Raffaele Milan, Milano, Italy
Not yet recruiting
Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer
NCT07673211
- Conditions
- Cervical Cancer, Disease Attributes, Disease Progression, +18 more
- Locations
-
Not specified
Not yet recruiting
QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer
NCT07186868
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
- Locations
-
Not specified
Active, not recruiting
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
NCT04266886
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Dostarlimab and Cobolimab in Advanced Cervical Cancer
NCT06238635
- Conditions
- Advanced Cervical Carcinoma, Cervical Cancer, Female Urogenital Diseases, +15 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT04380805
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
- Locations
-
- Womens Cancer Research Foundation Newport Beach, California, United States
- Sylvester Comprehensive Cancer Center Miami, Florida, United States
- BRCR Medical Center Plantation, Florida, United States
- Augusta University Medical Center Augusta, Georgia, United States